REFERENCES
- Lugon JR. Uremic pruritus: A review. Hemodialysis International. 2005; 9: 180–188
- Schwartz IF, Iaina A. Uremic pruritus. Nephrol Dial Transplant. 1999; 14: 834–839
- Urbonas A, et al. Uremic pruritus—an update. Am J Nephrol. 2001; 21: 343–350
- Mettang T, Pauli-Magnus C, Alscher DM. Uremic pruritus—new perspectives and insights from recent trials. Nephrol Dial Transplant. 2002; 17: 1558–1563
- Kimmel M, et al. The role of micro-inflammation in the pathogenesis of uremic pruritus in hemodialysis patients. Nephrol Dial Transplant. 2006; 21: 749–755
- Rose MA, Kam CA. Gabapentin: Pharmacology and its use in pain management. Anaesthesia. 2002; 57: 451–462
- Taylor CP, et al. A summary of mechanistic hypotheses of gabapentin pharmacology. Epilepsy Research. 1998; 29: 233–249
- Bassilios N, Launay-Vacher V, Khoury N, Rondeau E, Deray G, Sraer JD. Gabapentin neurotoxicity in a chronic hemodialysis patient. Nephrol Dial Transplant. 2001; 16: 2112–2113
- Gunal AI, et al. Gabapentin therapy for pruritus in hemodialysis patients: A randomized, placebo-controlled, double-blind trial. Nephrol Dial Transplant. 2004; 19: 3137–3139
- Maneti L, et al. Gabapentin in the treatment of uremic itch: An index case and a pilot evaluation. J Nephrol. 2005; 18: 86–91
- Jedras M, Zakrzewska-Pniewska B, Wardyn K, Switalski M. Uremic neuropathy. II. Is pruritus in dialyzed patients related to neuropathy?. Pol Arch Med Wewn. 1998; 99: 462–469
- Breneman DL, Cardone JS, Blumsack RF, Lather RM, Seaile EA, Pollack VE. Topical capsaicin for the treatment of hemodialysis-related pruritus. J Am Acad Dermatol. 1992; 26: 91–94
- Kumagai H, Utsumi J, Suzuki T, Hayasi M, Saruta T. Endogenous opioid system in uremic pruritus. Abstracts of the Joint Meeting of Seventh World Conference on Clinical Pharmacology and Therapeutics IUPHAR & 4th Congress of the European Association for Clinical Pharmacology and Therapeutics. Br J Clin Pharmacol. 2000; 282
- Okano K, Tagashi Y, Umeuchi H, Ando N, Tanaka T, Kawamura K, Endo T, Kamei J, Nagase H. Anti-pruritic effect of opioid kappa receptor agonist TRK-820. Abstracts of the Joint Meeting of Seventh World Conference on Clinical Pharmacology and Therapeutics IUPHAR & 4th Congress of the European Association for Clinical Pharmacology and Therapeutics. Br J Clin Pharmacol. 2000; 283
- Morton CA, Lafferty M, Hau C, Henderson I, Jones M, Lowe JG. Pruritus and skin hydration during dialysis. Nephrol Dial Transplant. 1996; 11: 2031–2036
- Cho YL, Liu HN, Huang TP, Tarng DC. Uremic pruritus: Roles of parathyroid hormone and substance P. J Am Acad Dermatol. 1997; 36: 538–541
- Friga V, Linos A, Linos D. Is aluminium toxicity responsible for uremic pruritus in chronic hemodialysis patients?. Nephron. 1997; 75: 48–53
- Dimkovia N, Djukanovia L, Radmilovia A, et al. Uremic pruritus and skin mast cells. Nephron. 1992; 61: 5–9
- Mettang T, Fritz P, Weber J, et al. Uremic pruritus in patients on hemodialysis or continuous ambulatory peritoneal dialysis: The role of plasma histamine and skin mast cells. Clin Nephrol. 1990; 34: 136–141
- Ashmore SD, Jones CH, Newstead CG, Daly MJ, Chrystyn H. Ondansetron therapy for uremic pruritus in hemodialysis patients. Am J Kidney Dis. 2000; 35: 827–831
- Mettang T, Fritz P, Weber J. Uremic pruritus in patient on hemodialysis or CAPD: The role of plasma histamine and skin mast cell. Clinical Nephrology. 1990; 34(3)136–141
- Peer G, Kivity S, Agami O, et al. Randomised cross over trial of naltrexone in uremic pruritus. Lancet. 1996; 348: 1552–1554
- Virga G, Visentin I, Lamilia V, et al. Inflammation and pruritus in hemodialysis patients. Nephrol Dial Transplant. 2002; 11: 2164–2169
- Morachiello P, et al. Combined hemodialysis-hemoperfusion in the treatment of secondary hyperparathyroidism of uremic patients. Blood Purif. 1991; 9: 148–152